Eaton Vance Worldwide Health Sciences Fund Class I (EIHSX)

EIHSX Holdings List

As of Sep 30, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.83%	115,906
2	ABBV	AbbVie Inc.	7.43%	262,266
3	LON: AZN	AstraZeneca PLC	5.84%	311,447
4	SWX: ROG	Roche Holding AG	5.19%	127,381
5	ABT	Abbott Laboratories	4.90%	298,915
6	JNJ	Johnson & Johnson	4.44%	195,782
7	UNH	UnitedHealth Group Incorporated	3.86%	91,226
8	ZTS	Zoetis Inc.	3.30%	184,111
9	ISRG	Intuitive Surgical, Inc.	3.23%	58,925
10	BMY	Bristol-Myers Squibb Company	3.11%	563,654
11	BSX	Boston Scientific Corporation	2.91%	243,280
12	SYK	Stryker Corporation	2.90%	64,081
13	VRTX	Vertex Pharmaceuticals Incorporated	2.72%	56,841
14	EPA: SAN	Sanofi	2.60%	224,029
15	GILD	Gilead Sciences, Inc.	2.56%	188,375
16	CPH: NOVO.B	Novo Nordisk A/S	2.46%	360,287
17	DHR	Danaher Corporation	2.44%	100,636
18	MDT	Medtronic plc	2.16%	185,134
19	TMO	Thermo Fisher Scientific Inc.	2.15%	36,137
20	NBIX	Neurocrine Biosciences, Inc.	2.10%	122,298
21	SWX: LONN	Lonza Group AG	2.07%	25,269
22	IDXX	IDEXX Laboratories, Inc.	1.99%	25,410
23	ASX: CSL	CSL Limited	1.85%	115,187
24	EW	Edwards Lifesciences Corporation	1.61%	169,540
25	ARGX	argenx SE	1.58%	17,543

Showing 25 of 44 holdings

Subscribe to see the full list

Asset Allocation

Asset Class	% Weight
Stocks	99.42%
Not Classified	0.58%
Cash	0.00%

Sector Breakdown

Sector	% Weight
Health Care	91.65%
Other	7.91%
Materials	0.44%

Country Breakdown

Sector	% Weight
United States	77.90%
Switzerland	9.73%
United Kingdom	5.14%
France	3.11%
Australia	1.92%
Japan	1.67%
New Zealand	0.33%
Other	0.20%